Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
03.10.25
/
50%
€134.00
Target price
03.10.26
€167.19
Performance (%)
11.94%
Price
23.12.25
€147.00
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr currently has a performance of 11.94%. This prediction currently runs until 03.10.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 5.000% | 5.000% |
| iShares Core DAX® | 0.650% | 3.212% |
| iShares Nasdaq 100 | 1.650% | 0.322% |
| iShares Nikkei 225® | 1.232% | 1.549% |
| iShares S&P 500 | 1.413% | 0.282% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $121.00 to $196.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat